This is the list of the largest public listed companies in the Biotechnology industry in the world by market capitalization with links to their reference stock.
Company Profile:
TG Therapeutics, Inc.
Market Cap (USD):
$4.52 B
Country:
United States
Sector:
US Healthcare
Industry:
US Biotechnology
Company Profile:
Krystal Biotech, Inc.
Market Cap (USD):
$4.46 B
Country:
United States
Sector:
US Healthcare
Industry:
US Biotechnology
Company Profile:
Verona Pharma plc
Market Cap (USD):
$4.43 B
Country:
United Kingdom
Sector:
UK Healthcare
Industry:
UK Biotechnology
Company Profile:
Scholar Rock Holding Corporation
Market Cap (USD):
$4.25 B
Country:
United States
Sector:
US Healthcare
Industry:
US Biotechnology
Company Profile:
Reata Pharmaceuticals, Inc.
Market Cap (USD):
$4.19 B
(July 1, 2023)
Country:
United States
Sector:
US Healthcare
Industry:
US Biotechnology
Company Profile:
Mirati Therapeutics, Inc.
Market Cap (USD):
$4.15 B
(Jan. 1, 2024)
Country:
United States
Sector:
US Healthcare
Industry:
US Biotechnology
Company Profile:
Ultragenyx Pharmaceutical Inc.
Market Cap (USD):
$4.07 B
Country:
United States
Sector:
US Healthcare
Industry:
US Biotechnology
Company Profile:
Telix Pharmaceuticals Limited
Market Cap (USD):
$4.04 B
(July 1, 2024)
Country:
Australia
Sector:
Australian Healthcare
Industry:
Australian Biotechnology
Company Profile:
Immunovant, Inc.
Market Cap (USD):
$3.96 B
Country:
United States
Sector:
US Healthcare
Industry:
US Biotechnology
Company Profile:
Xiamen Amoytop Biotech Co. Ltd
Market Cap (USD):
$3.93 B
Country:
China
Sector:
Chinese Healthcare
Industry:
Chinese Biotechnology
Company Profile:
ADMA Biologics, Inc.
Market Cap (USD):
$3.92 B
Country:
United States
Sector:
US Healthcare
Industry:
US Biotechnology
Company Profile:
Viking Therapeutics, Inc.
Market Cap (USD):
$3.89 B
Country:
United States
Sector:
US Healthcare
Industry:
US Biotechnology
Company Profile:
PharmaEssentia Corp
Market Cap (USD):
$3.85 B
(Jan. 1, 2024)
Country:
Taiwan
Sector:
Taiwanese Healthcare
Industry:
Taiwanese Biotechnology
Company Profile:
Turning Point Therapeutics, Inc.
Market Cap (USD):
$3.81 B
(Aug. 1, 2022)
Country:
United States
Sector:
US Healthcare
Industry:
US Biotechnology
Company Profile:
CRISPR Therapeutics AG
Market Cap (USD):
$3.78 B
Country:
Switzerland
Sector:
Swiss Healthcare
Industry:
Swiss Biotechnology
Company Profile:
ChemoCentryx, Inc.
Market Cap (USD):
$3.74 B
(Oct. 1, 2022)
Country:
United States
Sector:
US Healthcare
Industry:
US Biotechnology
Company Profile:
Apellis Pharmaceuticals, Inc.
Market Cap (USD):
$3.73 B
Country:
United States
Sector:
US Healthcare
Industry:
US Biotechnology
Company Profile:
Crinetics Pharmaceuticals, Inc.
Market Cap (USD):
$3.64 B
Country:
United States
Sector:
US Healthcare
Industry:
US Biotechnology
Company Profile:
Shanghai Junshi Biosciences Co. Ltd
Market Cap (USD):
$3.58 B
Country:
China
Sector:
Chinese Healthcare
Industry:
Chinese Biotechnology
Company Profile:
Abcam plc
Market Cap (USD):
$3.58 B
(Dec. 1, 2022)
Country:
United Kingdom
Sector:
UK Healthcare
Industry:
UK Biotechnology
Company Profile:
PTC Therapeutics, Inc.
Market Cap (USD):
$3.56 B
Country:
United States
Sector:
US Healthcare
Industry:
US Biotechnology
Company Profile:
Rhythm Pharmaceuticals, Inc.
Market Cap (USD):
$3.55 B
Country:
United States
Sector:
US Healthcare
Industry:
US Biotechnology
Company Profile:
ImmunityBio, Inc.
Market Cap (USD):
$3.46 B
Country:
United States
Sector:
US Healthcare
Industry:
US Biotechnology
Company Profile:
Veracyte, Inc.
Market Cap (USD):
$3.40 B
Country:
United States
Sector:
US Healthcare
Industry:
US Biotechnology
Company Profile:
Avidity Biosciences, Inc.
Market Cap (USD):
$3.37 B
Country:
United States
Sector:
US Healthcare
Industry:
US Biotechnology
Company Profile:
Denali Therapeutics Inc.
Market Cap (USD):
$3.35 B
Country:
United States
Sector:
US Healthcare
Industry:
US Biotechnology
Company Profile:
VitaSpring Biomedical Co. Ltd
Market Cap (USD):
$3.30 B
Country:
United States
Sector:
US Healthcare
Industry:
US Biotechnology
Company Profile:
Camurus AB
Market Cap (USD):
$3.30 B
(July 1, 2024)
Country:
Sweden
Sector:
Swedish Healthcare
Industry:
Swedish Biotechnology
Company Profile:
Laboratorios Farmaceuticos Rovi, SA
Market Cap (USD):
$3.20 B
Country:
Spain
Sector:
Spanish Healthcare
Industry:
Spanish Biotechnology
Company Profile:
Recursion Pharmaceuticals, Inc.
Market Cap (USD):
$3.12 B
Country:
United States
Sector:
US Healthcare
Industry:
US Biotechnology